Best Retirement Stocks: Smith & Nephew (SNN)
Dividend Yield: 2.4%
If you drink rum, there’s a distinct possibility you might get this U.K. medical device company mixed-up with Wray and Nephew, a Jamaican maker of overproof rum now owned by Davide Campari-Milano SpA (ADR) (OTCMKTS:DVDCY).
Now that I’ve cleared up any possible confusion, let me tell you why I think you should own Smith & Nephew plc (ADR) (NYSE:SNN).
The biggest reason to own SNN is that it has been very reliable in paying its annual dividend — for every year since 1937.
Beyond its dividend, Smith & Nephew operates in some very demographic-friendly segments of the healthcare sector, including providing reconstructive hip and knee implants, along with joint repair for sports-related injuries.
As people live longer, the combination of sports injuries due to cardio-related exercise trying to keep old age from setting in — along with people’s joints deteriorating from aging — ensures the company will continue to have a large demographic to pull from.
SNN has seriously underperformed in the past few years, but the company’s move to participate in higher-growth areas of healthcare while building its business in emerging markets should see it revert to the mean in the next few years as operating profits and margins improve.